Innovations in cervical cancer diagnosis for low resource settings using advanced optical imaging and machine learning diagnostic algorithms.
Award amount
$299,992Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CALLA HEALTH FOUNDATION
- Proposal award date
- 2019-09-13
- Contract end date
- 2020-03-31
- UEI
- U93NDFLVGKL3
- Solicitation number
- PAR18-801
- Topic code
- 102
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development and validation of patient-ready Callascope for cervical imaging
- Optimizing ablation of cervical precancer with ethyl cellulose ethanol to enable translation to women in low and middle-income countries
- Innovations in cervical cancer diagnosis for low resource settings using advanced optical imaging and machine learning diagnostic algorithms.
- Optimizing delivery of ethyl cellulose ethanol for ablation of cervical precancer
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer
Research funding history
5 SBIR/STTR records share this UEI (2019–2025). Reported award amounts total $4,733,852. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services